Systemic Sclerosis

Clodoveo Ferri, Gabriele Valentini, Franco Cozzi et al. · Medicine · 2002

Introduction Systemic sclerosis (SSc) is a connective tissue disease clinically characterized by different degrees of skin fibrosis and visceral organ involvement (17,19,22). The etiology of SSc remains obscure; the disease appears to be the result of a multistep and multifactorial process, including immune system alterations, genetic and exogenous, and toxic or infectious factors (17,19,22). The epidemiology of SSc is not definitely established due to the relative rarity of the disease, the difficulty in diagnosis, and its extreme clinical variability. SSc affects females more frequently than males, with a peak of incidence between ages 45 and 64 years (19,22). There seems to be an increased incidence of the disease in blacks, particularly in black females, but no other significant racial differences in distribution. Various HLA studies in SSc patients failed to identify any clearcut associations, even if a role of specific HLA antigens might be hypothesized for particular clinico-serologic SSc subsets (19). Moreover, familial factors are certainly important for SSc development: it is not rare to observe a scleroderma patient with 1 or more firstdegree relatives with another autoimmune systemic disorder, such as Raynaud phenomenon, systemic lupus, or rheumatoid arthritis (19,22). The annual incidence (new cases/population at risk per year) of SSc varies largely among different surveys (from 0.6 to 19.1 per million/year), as does the estimated prevalence (number of cases living at a particular time or during a given time interval per million of population at risk: from 126 to 1,500). The actual incidence and prevalence of the disease are generally underestimated; the minimum estimated values are 20/million per year and 1,500/million, respectively. The number of undiagnosed cases, especially in the oldest surveys, might be significant; this is due, at least in part, to the clinical characteristics of the disease. SSc includes a wide spectrum of symptoms, varying from very mild cutaneous and internal organ involvement to diffuse fibrosis responsible for organ failure (4,11,17,19,22). A variable combination of organ damage, or, less frequently, a severe, single organ involvement, is responsible for SSc morbidity and mortality. Among different connective tissue diseases, SSc shows the poorest prognosis (17,19,22). The availability of well-recognized criteria for diagnosis, disease activity (34), and severity (21), as well as of valuable prognostic parameters, should be decisive for timely patient identification, clinical assessment, and management. In the absence of valuable diagnostic criteria, patients are usually classified according to the American College of Rheumatology (formerly ARA) preliminary criteria for SSc classification (32) (Table 1). The introduction of capillaroscopic SSc pattern (capillary dilation with or without capillary dropouts) and SSc-related serum autoantibodies might improve the usefulness of classification criteria, particularly in discriminating the early stage of the disease. However, these criteria are not intended to assist in the diagnosis of individual patients, which is based on the careful observation of different clinical and laboratory features.TABLE 1: Classification criteria and diagnostic parameters of systemic sclerosis (SSc)Diagnosis of SSc in patients with diffuse cutaneous sclerosis is quite easy; on the contrary, it can be particularly difficult during the early stage of the disease or in the presence of sine scleroderma SSc (ssSSc) (Figure 1). In these instances, isolated Raynaud phenomenon (Table 2) or other connective tissue diseases must be ruled out. Diagnosis of SSc is currently based on the presence of cutaneous manifestations (symmetrical, truncal, and/or acral skin sclerosis, skin ulcers, digital pitting scars, telangiectasias, calcinosis), typical internal organ involvement (lung fibrosis, esophageal dysfunction, heart and/or renal alterations), capillaroscopic scleroderma pattern, and autoantibody profile (see Table 1, Figures 1–3).TABLE 2: Approach to apparently isolated Raynaud phenomenonFig. 1: Systemic sclerosis (SSc) classification according to skin sclerosis extent (black areas). Sine scleroderma SSc (ssSSc): absence of cutaneous sclerosis in patients with typical SSc visceral organ involvement, capillaroscopic changes, and serum autoantibodies. Limited cutaneous scleroderma (lcSSc): skin sclerosis of fingers (sclerodactyly) with or without mild sclerotic lesions at neck, face, and armpits. Intermediate cutaneous scleroderma (icSSc): sclerosis of upper and lower limbs, neck and face, without truncal involvement. Diffuse cutaneous scleroderma (dcSSc): distal and truncal skin sclerosis.Fig. 2: Capillaroscopic findings. a. Normal subject. b. Patient with isolated Raynaud phenomenon. c. and d. Typical scleroderma patterns:c. diffuse capillary enlargement (megacapillaries), d. presence of megacapillaries and large avascular areas (capillary dropouts).Fig. 3: Cutaneous manifestations of SSc. A. Patient with limited cutaneous SSc (lcSSc): mild perioral sclerosis and diffuse telangiectasias. B. Patient with diffuse cutaneous SSc: marked skin sclerosis at face and neck, diffuse hypermelanosis with some hypochromic areas. C. Digital pitting scars and pulp ulcers in lcSSc. D. Subcutaneous calcinosis at knees in lcSSc.The large variability in the disease course, generally characterized by progressive, often subclinical, visceral organ deterioration, makes the long-term outcome of SSc extremely unpredictable. The clinical and autoantibody pattern of the disease observed in different patient populations may also vary widely (2,8,10–15,17,19,22,30,31,35). The relationship between clinico-serologic features of SSc and survival rates can give us useful prognostic parameters. Moreover, follow-up studies on different patient series can yield new insights on the possible variations of SSc pathomorphism during the last few decades. These changes coul

Cited by 764 works. doi:10.1097/00005792-200203000-00004 Open-access PDF

Authors

References